01/21/2025 3:52 PM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 3:17 PM | MiNK Therapeutics (Filer)
| Form DEF 14A | |
12/06/2024 4:09 PM | MiNK Therapeutics (Filer)
| Form PRE 14A | |
12/03/2024 9:35 AM | MiNK Therapeutics (Issuer) WIINBERG ULF (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 9:38 AM | Behner Peter (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 9:44 AM | Corvese Brian (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 9:44 AM | MiNK Therapeutics (Issuer) Ryan Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2024 8:15 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 7:18 AM | Corvese Brian (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 7:22 AM | MiNK Therapeutics (Issuer) WIINBERG ULF (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for INKT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
09/05/2024 7:23 AM | Behner Peter (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 7:23 AM | MiNK Therapeutics (Issuer) Ryan Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2024 11:15 PM | MiNK Therapeutics (Filer)
| Form EFFECT | |
08/16/2024 3:39 PM | MiNK Therapeutics (Filer)
| Form 424B3 | |
08/13/2024 3:34 PM | MiNK Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/13/2024 3:18 PM | MiNK Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/13/2024 6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2024 1:22 PM | Corvese Brian (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 1:24 PM | MiNK Therapeutics (Issuer) WIINBERG ULF (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 1:27 PM | MiNK Therapeutics (Issuer) Ryan Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 1:27 PM | Behner Peter (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 3:33 PM | GKCC, LLC (Filed by) MiNK Therapeutics (Subject)
| Form SC 13G | |
05/16/2024 7:02 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 6:30 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 6:28 AM | MiNK Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 4:25 PM | MiNK Therapeutics (Filer)
| Form DEF 14A | |
03/21/2024 6:00 AM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 5:00 PM | Corvese Brian (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:00 PM | MiNK Therapeutics (Issuer) WIINBERG ULF (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:00 PM | MiNK Therapeutics (Issuer) Ryan Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:00 PM | Behner Peter (Reporting) MiNK Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:05 PM | MiNK Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |